MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.480
-0.060 (-3.90%)
May 9, 2025, 11:25 AM - Market open
MacroGenics Employees
MacroGenics had 341 employees as of December 31, 2024. The number of employees increased by 2 or 0.59% compared to the previous year.
Employees
341
Change (1Y)
2
Growth (1Y)
0.59%
Revenue / Employee
$439,771
Profits / Employee
-$196,381
Market Cap
93.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
Eli Lilly and Company | 47,000 |
MGNX News
- 2 days ago - MacroGenics Announces Date of First Quarter 2025 Financial Results - GlobeNewsWire
- 7 days ago - MacroGenics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 7 weeks ago - MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call - GlobeNewsWire
- 2 months ago - MacroGenics: Stacking Up A Lot Of Headwinds - Seeking Alpha
- 2 months ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results - GlobeNewsWire